Agency Q4 earnings roundup
WPP saw a decline in healthcare and pharma in 2019 due to assignment losses.
Earnings
Pharma Q4 earnings roundup
Merck announced a spin-off of its biosimilar, women’s health and legacy products.
WPP sees ‘slightly subdued’ new business outlook for big pitches
WPP is defending its media account with Novartis this year.
Interpublic Group posts 3% organic growth in Q2
IPG owns networks McCann Health and FCB Health, as well as Healix, Golin, Virgo Health and ReviveHealth.
Publicis Groupe reports 15% hike in first-half profit, but struggles in North America
The holding company’s performance was held aloft by strong results in Europe, Asia and the Middle East.
Omnicom healthcare revenue jumps 8.4% in Q2
The healthcare agencies posted the highest organic revenue growth of Omnicom’s five disciplines.
IPG CEO Michael Roth pushes power of ‘agency brands’ in Q1 call
“The best creative ideas come from strong agency brands,” said the Interpublic CEO.
Oncology leads the charge in pharma Q1 earnings
Q1 earnings from Bristol-Myers Squibb, Bayer, Johnson & Johnson, AbbVie and Novartis showed strong growth by oncology drugs.
Ascential reports revenue decline at Cannes Lions, MediaLink
Revenue at Ascential’s marketing division fell 8% in 2018.
